Reports Reveal That The Cure For Ebola Is On Its Way

2018 might prove to be a year very lucky for people suffering Ebola. It has been guessed that by the year 2018, a vaccine will be made which is destined to fight against the Ebola virus, as reported by World Health Organization.

Most of the inhabitants of the West African countries suffer from this disease. Guinea is one of them. A series of experimental trials were done on people of this west African country. The target group was the Ebola sufferers, and the results proved that this vaccine could provide complete safety.

The vaccine is now being followed for the purpose of approval. The best thing about this vaccine is that it does not have any side effects. The people which were tested with this had no adverse outcomes except the protection.

However, according to BBC News, one person did see the side effects, and the test conductors thought it might be due to the hypodermic injection. But the vaccine still proved to be helpful for the person. One thing that is still being thought about is how helpful it might prove to be the kids or young ones, as they are not yet tested.

Marie Paule who belongs from the World Health Organisation told how this vaccine is helpful. Dr. Kieny, who conducted the study, and also played a role in experimentation is utterly happy about her discovery of the vaccine. She says that when the next time Ebola becomes common especially in the parts of Africa, there would he some hope through this vaccine.

This vaccine would at least be a defense, and there would be something to cure and help the ones
suffering and dying. The recent spread of Ebola proved how badly a vaccine is needed. And 2018 might be the one to bring it to use, after a lengthy wait. But this does not end here. There are many other firms and companies who are working on this too. Many do realize how much the need for the vaccine and cure is increasing and a lot of work is being done on the purpose of making the treatments and ways to prevent Ebola.

© 2024 ParentHerald.com All rights reserved. Do not reproduce without permission.

Join the Discussion
Real Time Analytics